DAB1 and Alzheimer disease: Single-target IHC in a non-AD control with Aβ plaques (Thal phase 3) but no overt pTau pathology (Braak stage 0) revealed multiple, globular plaque-associated Dab1 accumulations that were most prominent in L5 and L3 (Additional file 1: Ext Fig. S9.2), with little or no pTauSer202/Thr205 or pPSD95Thr19 evident in serial sections.